Clinical Trial

Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells for the Treatment of Primary Progressive Multiple Sclerosis

Study acronym: MAESTRO-4MS
Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
In this study, we propose, for the first time, to test the safety and the potential efficacy of repeated allogenic Adipose tissue-derived Mesenchymal Stromal Cells IT injections in Primary Progressive Multiple Sclerosis patients.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-09-10; most recent amendment 2025-12-31.
Status change: Active, Not Recruiting → Recruiting 2025-03-13
Status change: Not Yet Recruiting → Active, Not Recruiting 2024-12-23
Trial Details
NCT Number NCT06592703
Lead Sponsor Rennes University Hospital
Collaborators: Etablissement Français du Sang
Conditions Multiple Sclerosis
Enrollment 10 participants
Start Date 2025-03-06
Primary Completion 2029-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-05